# Ajinomoto Althea, Inc. – FDA 483, Jan 16, 2023

Source: https://www.keypedia.com/records/483/ajinomoto-althea-inc/31d386f5-e5ea-4cf9-b563-54c74ade61ef

> FDA 483 for Ajinomoto Althea, Inc. on January 16, 2023. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Ajinomoto Althea, Inc.
- Inspection Date: 2023-01-16
- Product Type: biologics
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)
- Summary: Ajinomoto Althea, Inc. DBA Ajinomoto Bio-Pharma Services in San Diego, CA, was inspected and received a Form 483 with three observations. The inspection revealed deficiencies in quality oversight of validation activities, facility and equipment maintenance, and adherence to quality control unit procedures. These issues indicate a need for improved GMP compliance in critical manufacturing and laboratory operations.

## Related Documents

- [483 - 2025-05-09](https://www.keypedia.com/records/483/ajinomoto-althea-inc/460eb7ec-a1f2-489e-af6c-54a4f2adef31) — date: May 9, 2025
- [483 - 2023-09-20](https://www.keypedia.com/records/483/ajinomoto-althea-inc/189c64ec-06f0-442c-9aaf-eb9ea48f6a0b) — date: September 20, 2023
- [483 - 2023-02-09](https://www.keypedia.com/records/483/ajinomoto-althea-inc/580fc4cc-211e-489a-8466-337a0c433bff) — date: February 9, 2023
- [483 - 2021-05-25](https://www.keypedia.com/records/483/ajinomoto-althea-inc/a6e715c6-2e49-4494-ad26-7c9e6bc7e8c4) — date: May 25, 2021
- [EIR - 2019-12-20](https://www.keypedia.com/records/eir/ajinomoto-althea-inc/668193bb-da58-4599-829f-e401abd98ac9) — date: December 20, 2019

## Related Officers

- [Regulatory Scientist at FDA](https://www.keypedia.com/people/yi-wang/f5355ae0-ae28-452f-829a-786b7ebc4791)
- [Consumer Safety Officer (Inspector)](https://www.keypedia.com/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84)
- [Investigator](https://www.keypedia.com/people/michael-r-shanks/dd24952b-4309-451e-afe8-f68892cd7bac)

Company: https://www.keypedia.com/companies/ajinomoto-althea-inc/75fb5ea8-b86f-45c1-946e-80c73765f544

Office: https://www.keypedia.com/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd
